Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.45% | -130.16% | -183.48% | -20.84% | 83.24% |
| Total Depreciation and Amortization | 37.61% | 37.97% | 32.70% | 27.29% | -4.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.27% | 7,791.80% | 11,056.00% | 77.46% | -115.59% |
| Change in Net Operating Assets | -94.60% | 118.73% | 56.55% | -25.01% | -49.11% |
| Cash from Operations | -16.16% | 63.07% | 56.72% | -17.19% | -15.81% |
| Capital Expenditure | -5.37% | -16.88% | 25.38% | -10.25% | -26.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -502,000.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.14% | 18,983.33% | -176.73% | 75.05% | 148.76% |
| Cash from Investing | -366.08% | -627.53% | -586.62% | -675.69% | 92.64% |
| Total Debt Issued | -100.00% | -- | -- | -- | 596,300.00% |
| Total Debt Repaid | 100.00% | -- | 54.40% | 99.63% | -- |
| Issuance of Common Stock | 1,664.29% | 258.33% | 726.32% | 291.67% | 180.00% |
| Repurchase of Common Stock | 50.64% | 43.72% | 24.91% | -156.03% | -197.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.35% | -3.23% | -2.68% | -3.43% | -3.99% |
| Other Financing Activities | 329.41% | -84.93% | -33.33% | 388.10% | 153.13% |
| Cash from Financing | -192.19% | 149.55% | 48.20% | 257.89% | 208.78% |
| Foreign Exchange rate Adjustments | -560.00% | -109.89% | -112.18% | 106.27% | -96.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.90% | 326.56% | -102.62% | -160.58% | 207.30% |